JAIME DIXON: Open Payments
NPI 1790068534 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 23 payments from 7 companies in 2025. Trend: 2023 $1,723 · 2024 $1,079 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $184 |
| HEARTFLOW, INC. | 1 | $126 |
| E.R. Squibb & Sons, L.L.C. | 5 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $50 |
| Novo Nordisk Inc | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: FFRct, LOKELMA, CAMZYOS, LifeVest, FARXIGA, LEQVIO, Wegovy, Ozempic.
Industry payments across WV — which companies pay providers there.
